Shield Therapeutics plc
SHIEF News Today: Stay Updated with the Latest Shield Therapeutics plc News in Real Time
Find SHIEF news now at Meyka AI. Stay informed with the latest Shield Therapeutics plc stocks updates, including price news, market analysis, and expert insights.
Blue Cross, Michigan Medicine End Dispute on May 27
Blue Cross Blue Shield of Michigan and Michigan Medicine reach five-year contract agreement, avoiding coverage disruption for 300,000 patients.
Swiss Police Treat Winterthur Stabbing as Terror Attack, May 29
Swiss police declare Winterthur train station stabbing a terrorist act. Suspect arrested after injuring three people.
Shell Repurchases 1.98M Shares on May 27, Continues Buyback Program
Shell repurchases 1.98M shares on May 27 as part of ongoing buyback program. Stock trades at $83.83 with Meyka grade A- and analyst consensus Buy.
Jharkhand Minimum Wage Rises 1 April: Workers Get Higher Pay
Jharkhand minimum wages rise from April 1, 2026. Semi-skilled workers earn ₹540 daily, skilled workers ₹712 daily, with dearness allowance included.
Minneapolis Police Chief O’Hara Resigns After Investigation, May 27
Minneapolis Police Chief Brian O’Hara resigns following investigation into interference with probe of his conduct. Katie Blackwell named acting chief.
Trump Cancels Camp David Cabinet Meeting Due to Weather, May 27
Trump cancels Camp David Cabinet trip citing weather; meeting moves to White House. Iran tensions and peace talks remain uncertain after U.S. strikes.
Rolls-Royce Shares Rise on Defense Demand and Battery Project, May 27
Rolls-Royce Holdings (RR.L) shares rise on defense demand and UK battery storage involvement, trading at 1,248.80p with aerospace growth.
Brent Crude Hits $100 Again on Iran Strikes, May 26
Brent crude oil climbs to $100/barrel after US strikes on Iran. Peace talks uncertain as global oil inventories tighten and UK energy bills rise 13%.
BX Stock May 26: Legal & General Cuts $713M Blackstone Position
Legal & General cuts Blackstone stake to $713.44M in Q4 amid real estate challenges. SEC filing details institutional pressure on BX stock.